Anti-malarial drug touted by Trump was subject of CIA warning to employees
The politically charged debate over hydroxychloroquine — medical experts say there’s no conclusive evidence it does what Trump has suggested — underscores a recurring phenomenon in this administration, in which the president stakes out a very public, sometimes controversial position on a subject only to have agencies within the government chart a different, more cautious approach.
A CIA website for employees with questions about the coronavirus addressed the topic on March 27, noting there had been media reports suggesting the drug “has activity against the COVID-19 virus.”
“At this point, the drug is not recommended to be used by patients except by medical professionals prescribing it as part of ongoing investigational studies. There are potentially significant side effects, including sudden cardiac death, associated with hydroxychloroquine and its individual use in patients need to be carefully selected and monitored by a health care professional,” the answer said, before adding in bold type: “Please do not obtain this medication on your own.”
A CIA spokesman declined to comment about internal workforce communications. The advice was posted …continued .
[Source: Washington Post]